As you’ve likely read in David’s last blog post, a new and improved ImmunoPCTN is now available. The acronym PCTN refers to Prostate Cancer Targeted Nutrition, in case you are wondering. As a formulator and the Medical Director at XY Wellness, I am relentlessly thinking about improving our formulations. And that’s what we did with ImmunoPCTN.
What’s new with ImmunoPCTN?
The goal with ImmunoPCTN is to strengthen immunity and reduce abnormal inflammation – both intricately involved in prostate cancer. We replaced Modified Citrus Pectin with the botanicals Andrographis and Magnolia bark extract with that goal in mind. The ingredient list for ImmunoPCTN now consists of Curcumin, Boswellia, Grape Seed Extract, Green tea extract, Pomegranate fruit extract, Reishi mushroom, Andrographis, and Magnolia bark extract.
Why Magnolia Bark and Andrographis?
Magnolia bark and Andrographis complements the already potent anti-inflammatory and immune benefits of curcumin, Boswellia, Grape seed extract, Reishi mushroom, and pomegranate extract.
How does Andrographis and Magnolia bark make the formula better?
Components of the Andrographis plant and Magnolia bark lower excess inflammatory chemical called Interleukin-6 (IL-6) and Nf-kB. That’s important because too much IL-6 seems to increase PSA and prostate cancer risk as does excess Nf-kB.
Magnolia bark (and its active ingredient, Honokiol):
How to take the new and improved ImmunoPCTN?
Take two pills twice a day, with or without food.
A final note on the new and improved ImmunoPCTN
It took much research of the scientific literature to reformulate and improve ImmunoPCTN. I am very happy with the outcome. You will be too. Remember, ImmunoPCTN works synergistically with GDtoxSel to offer optimal protection. Also, as you’ve heard from us many times, dietary supplements complement medical treatments when necessary, along with the XY Wellness lifestyle roadmap; it does not replace it.
I wish you continued success on your wellness journey.
Yours in Good Health,
Dr. Geo, Co-founder & Medical Director